NovAb, Inc.
Biotechnology company · Tucker, Georgia, United States
NovAb, Inc. is a biotechnology company headquartered in Tucker, Georgia, United States. Its earliest recorded incorporation is in 2013. It has received 6 US government small-business research awards (SBIR/STTR) from health agencies, $1.2 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $65,000 sold in a notice filed in 2026.
NovAb at a glance
What does NovAb do?
US government research funding
6 SBIR/STTR small-business research awards from US health agencies, $1.2 million in total (2014 to 2023). NIH funding came from the National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Cancer Institute.
Private fundraising reported to the SEC
9 Form D notices; the most recent reported $65,000 sold (2026).
Frequently asked questions about NovAb
Where is NovAb headquartered?
NovAb, Inc. is headquartered in Tucker, Georgia, United States.
What does NovAb do?
NovAb, Inc. is a biotechnology company.
When was NovAb founded?
The earliest incorporation on record for NovAb, Inc. is in 2013, according to public company registers.
Similar companies
- Expression Therapeutics, LLCTucker, Georgia, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences